Study offers new insights for bevacizumab use in patients with brain cancer

mdanderson has 392 videos Subscribe Here

Description: Many glioblastoma patients treated with bevacizumab (Avastin®) have significant deterioration in neurocognitive function, symptoms and quality of life, and these changes often predict treatment outcomes, according to new research from The University of Texas MD Anderson Cancer Center.
Shared By : mdanderson
Posted on : 06/04/13
Added : 4 years ago
Category : Brain Cancer

Tags: glioblastoma


Nothing found.

More From mdanderson

Nothing found.